MoneyWorks4Me

Alembic Pharmaceuticals planning to raise Rs 150 crore via NCDs

13 Mar 2019 Evaluate

Alembic Pharmaceuticals is planning to raise fund by issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 150 crore on Private Placement Basis under Tranche III. The company’s NCD committee will consider the same in the meeting to be held on March 19, 2019.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..